NCT02269904 - Fluorouracil Implants Used for Intraperitoneal Chemotherapy During Operation for Treatment of Phase III Gastric Cancer. | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

April 30, 2018

Study Completion Date

June 30, 2018

Conditions

DSF

Interventions

DRUG

Fluorouracil Implants

Fluorouracil Implants: 800mg, implanted in the abdominal cavity during operation.

DRUG

Xelox regimes

Xelox regimes: Capecitabine,1000 mg/m2，PO.BID, from D1 to D14; Oxaliplatin, 130 mg/m2，IV, D1 in each cycle. The cycle will repeated every 21 days till 6 cycles finished.

Trial Locations (1)

150000

RECRUITING

Heilongjiang Cancer Hospital, Harebin